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Together, these observations suggest that the determinants of mutation rates To examine determinants of mutation rates in somatic tissues, we downloaded 2 1 4 somatic mutation calls identified in four types of cancer from the Cancer Genome samples are listed below (Table 2 ). In all cases, both non-cancerous and tumor 2 1 9
tissues of patients were sampled and the exomes were sequenced using an 2 2 0
Illumina platform. In the studies, mutation calls shared by the normal and tumor 2 2 1 samples were removed (on the presumption that they are germline). What 2 2 2 remains are somatic mutations found at high enough frequency to be seen in a 2 2 3 large population of cells, which are therefore likely to predate the tumorigenesis, i.e., mutations that occurred in the pre-neoplastic tissues (Martincorena et al. For each type of cancer with more than one mutation annotation file available in 2 2 8 the TCGA data portal, we selected the file that included the largest number of Possible determinants of mutation rates. We considered the main factors 2 3 7 previously reported to be significantly correlated with mutation rates, namely 2 3 8 expression levels, replication timing, GC content and histone modification levels.
3 9
To quantify expression levels, we relied on gene expression data (measured as 2 4 0 RPKM) from the Genotype-Tissue Expression (GTEx) for breast, uterus, brain 2 4 1 cortex and liver tissues. We used gene expression levels of testis and ovary as 2 4 2 our proxy for germline expression. The effect of the replication timing on somatic mutation rates was argued to be 2 4 5 cell-type specific (Supek and Lehner 2015) . We therefore relied on Repli-Seq for lymphoblastoid cell lines (LCL) (provided in 10 kb windows) (Koren et al. 2012). We also tried using replication timing data from three somatic tissues 2 5 9
instead; the replication timing data are highly correlated among the tissues and 2 6 0 therefore the effects of mutation were estimated to be very similar (see Figure   2 6 1 S2). We also considered the effects of chromatin marks that had been shown to H3K9me3 and H3K27me3, two repressive marks associated with constitutively 2 6 7 and facultatively repressed genes, respectively. Levels of these marks were converted to gene-based histone modification levels by averaging across the 2 7 0 gene. We used the histone modification levels of adult ovary, breast 2 7 1 myoepithelial cells, brain hippocampus and adult liver as proxies for germline, 2 7 2 breast, brain and liver, respectively. In the following regression analysis, we 2 7 3 considered only three of four somatic tissues, as we could not obtain histone modification data for CESC. Finally, we computed exonic GC content as the 2 7 5 fraction of G or C residues in the union of exons in all isoforms of a given gene. Germline mutation studies relied on the UCSC Refseq gene annotation, whereas CpG Ti or other types of mutations in the coding exons of a gene and treated it 2 9 0
as an outcome of a sequence of independent Bernoulli trials with probability λ
is the probability of a mutation occurring in gene i. Transitions at CpG sites are thought to primarily occur due to spontaneous 2 9 4 deamination at methylated cytosines, a distinct mutational source, and thus their 2 9 5 determinants may be distinct from other mutation types (reviewed in Ségurel, Wyman, and Przeworski 2014). However, within CpG islands, most CpGs are of methylated CpGs, we therefore excluded CpG islands from the analyses of CpG Ti. CpG island annotations were downloaded from UCSC browser (track:
We considered gene expression levels measured in RPKM (X 1 ), replication 3 0 3
timing (X 2 ), mean histone modification levels (H3K9me3 as X 3 , H3K27me3 as X 4 ) 3 0 4
and GC content (X 5 ) as predictors. We also included L, the total number of CpG linear combination of these features scores:
We used R function glm.nb to estimate the coefficients, where β is an intercept
is the effect size of feature j, and X ୧ ୨
is the score for feature j in gene i. In corresponding expression data sets and then log-transformed the expression 3 1 8 level before normalization. We note that in this model, we are considering possible effects one at a time. Including interaction terms affects the estimates and significance levels but H3K27me3, which become less significant (see Figure S3 ). To examine whether the predictors have significantly different effects across 3 2 6
tissues, we combined the models into one by including a categorical variable C 3 2 7
for the tissue type (see Figure 2 ). In this approach:
3 2 8 C = 1 for somatic tissues, C = 0 for germline;
X 1 , X 2 , X 3 , X 4 and X 5 are the same genomic or epigenomic features as in the
β 5 are the effect sizes of features X 1 to X 5 for testis, features X 1 to X 5 compared to those in testis. We used the R function glm.nb to 3 3 3 estimate the coefficients. Similarly, in order to ask whether effects differ between CpG Ti and other type of 3 3 6 mutations in the same tissue, we included a binary variable C for the two 3 3 7 mutation types (see Figure S4 ).
3 3 8 C = 1 for CpG Ti, C = 0 for all other mutations;
All variables are set up the same way as in the combined model described 19,000 genes to consider. This annotation allowed us to classify mutations into 3 4 7 six types of mutation (A>C, A>G, A>T, G>A, G>C, G>T) on either TS or NTS.
3 4 8
There are thus 12 possible changes (each of the six on both strands). We then 3 4 9
calculated the mutation rate of any given type on NTS and TS separately, by
considering the number of corresponding mutations in the combined data sets, and Figure S5 ), we used bootstrap. Specifically, we created 100 samples, of the with replacement, and estimated the 95% CI from those 100 samples. We tested for strand asymmetry by a Chi-squared test. Because A>G strand mutation type that we found in all tissues (Figure 3) , we focused primarily on this 3 6 0 type, though we also considered A>T mutational patterns (see Figure S5 ). We began by applying our multivariable regression model (see Materials and 3 7 9
Methods) to compare the determinants of mutation rates per gene between the 3 8 0 two germline tissues and among the three somatic tissues (Figure 1) . Results for 3 8 1 germline mutations are very similar using testis or ovary expression profiles. In previous studies of divergence, we found a significant increase of germline 3 8 6 mutation rates with expression levels for both CpG Ti and other mutation types due to the scale of a gene considered here (rather than 100 kb windows). The effect of expression levels is most clearly seen using testis expression (P = 3 9 2 0.03 for CpG Ti; P = 1.4x10 -5 for other mutation types) than using ovary female germ cells than the testis expression profile is for male germ cells. In any 3 9 7
case, henceforth, we use testis expression profile for analysis of the germline 3 9 8 mutation rates. We note that our analysis of germline mutation relies on calls made in exome 4 0 1 studies of blood samples from six sets, including five cases and unaffected 4 0 2 controls (see Table 1 ). A previous study reported that in one set of cases, increased mutation rates with germline expression levels could be driven by a 4 1 0 similar ascertainment bias, we excluded the CHD set and obtained the same results (see Figure S6 ). We also reran the analysis, comparing the effects in the sizes were more uncertain (see Figure S7 ). Thus, our results suggest that the 4 1 5 increase in mutation rates with expression levels in testes is not a result of 4 1 6
focusing primarily on cases. Germline mutation rates are also associated with H3K27me3 levels. We also 4 1 9
found that, other than for CpG Ti, mutation rates in a gene increase with its GC on mutation rates is most pronounced for CpG Ti (see Figure S4 ). This finding 4 3 8
suggests that damage or repair of CpG Ti is tightly coupled to transcription. In all three somatic tissues, there is also a decrease in mutation rate with replication, is more effective in the early replicating regions of the genome; this 4 4 9 possibility is supported by the finding that this association is not detected in the it may seem surprising that replication timing is a significant determinant for the 4 5 2
LGG samples, given that neurons are post-mitotic, glial cells still retain their The only difference in the determinants of mutation rates across somatic tissues 4 5 7 appears to be the effect of GC content on CpG Ti rates: mutation rates decrease 4 5 8
with GC content in brain tissues and increase with GC content in liver and breast 4 5 9
tissues. This finding raises the possibility that damage or repair rates of CpG 4 6 0 sites differ in brain tissues (Lodato et al. 2015) . types). When we tested for this difference explicitly, by adding a binary variable the asymmetry is significant in all five data sets, with more mutation on the NTS differences among tissues, with significant excess on the transcribed strand in 4 9 0 the germline and LGG samples but a significant paucity on the NTS in BRCA and 4 9 1 2 5 CESC. These findings indicate a potential difference in either strand-biased 4 9 2 damage or in TCR (or both) among somatic tissues. In summary, the total 4 9 3 mutation rate appears to behave quite differently as a function of expression 4 9 4 levels in the germline and the soma (Figure 1 and 2) , despite the fact that we 4 9 5
observed clear evidence for TCR in both types of tissues (Figure 3) . To examine this difference in more detail, we focused on A>G mutations and 4 9 8 considered how the mutation rate and degree of asymmetry covary with levels increase, mutation rates and asymmetry increase, whereas in the soma, 5 0 1 asymmetry increases while mutation rates decrease. The same pattern is seen 5 0 2 when A>T mutation rate and asymmetry are considered (see Figure S5 ). This data sets respectively. For all replication timing data, high value means early. Red, blue and green bars represent the 95% CI of the deviation of the estimated coefficient from 5 1 8 the germline estimate; they are shown for BRCA (breast invasive carcinoma), LGG (brain lower 5 1 9
grade glioma) and LIHC (liver hepatocellular carcinoma) data sets respectively. For all replication 5 2 0 timing data, high value means early. denote 95% confidence intervals estimated by bootstrapping (see Materials and Methods). hepatocellular carcinoma). The error bars for both the strand asymmetry and the mutation rate We compared the determinants of mutation in the soma and the germline, using 5 3 9
the same unit of analysis (a coding region) and the same statistical model, and 5 4 0 applied it to similar exome data for germline de novo mutations and four types of earlier hints based on divergence data (Hodgkinson and Eyre-Walker 2011).
4 8
Notably, our results confirmed that somatic mutation rates decrease with 5 4 9
expression levels and reveal that, in sharp contrast, de novo germline mutation 5 5 0
rates increase with expression. This contrast suggests that transcription is 5 5 1 mutagenic in germline but not in soma, and that the DNA damage or repair 5 5 2 processes differ between them. One limitation of our comparison-and of previous studies of germline and 5 5 5 somatic mutation-is the need to rely on proxies for determinants of interest, second limitation is that we considered only two types of mutations (CpG Ti and 5 5 8 other). Other work indicates that while these two types capture most of the
